Jacques Biton, Directeur général (DG) / Managing Director

Philippe Pouletty, Président

06/09/2010 - 2010: A GOOD YEAR FOR IPOs

Stock market registrations in Europe seem to have picked up speed in Q2 2010. While 2009 was less than remarkable in that respect,… (n°472, EUROPE, page 1)

06/09/2010 - A RECEPTIVE BUT CAUTIOUS MARKET

“H1 2010 has been particularly paradoxical. On one hand we have observed several successful developments, such as the stock market flotations"… (n°472, FRANCE, page 3)

06/09/2010 - THE UPTURN STARTED AT THE END OF 2009 CONTINUES

“2009 will be remembered as a black year in the first decade of the 21st century year in biotechnologyfinancing. Or at least,…" (n°472, FRANCE, page 4)

24/05/2010 - “We need to close the gap between private equity and the European stock market”

Now that the biotechnology industry is on the brink of becoming profitable, as stated in Ernst & Young’s latest report “Beyond Borders: Global Biotechnology 2010”… (n°463, Expertise, page 6)

03/05/2010 - IPOs Europe: Truffle Capital gets IPO break

Truffle Capital, the French private equity mutual fund (FCPR) specialized in innovative companies (FCPI), with 400 M€ under its management,… (n°461, BREAKING NEWS, page 1)

03/05/2010 - White biotech goes green

A few months ago Biotech Finances featured the headline “White biotech: Germany sets out to conquer the USA”, a headline which in itself holds no surprise… (n°461, Eco Note by H. ELLA, page 2)

26/04/2010 - Deinove raises 12 M€ for its IPO

Deinove, the specialist in the application of deinococci bacteria to biofuels and green chemistry has announced its IPO… (n°460, Newsbite, page 7)

30/06/2008 - France Biotech présente son CA

(n°381, Newsbite, page 5)

25/02/2008 - Paris : Deinove mise sur les biotech blanches

Établir un pont entre les secteurs de la biotech et de l'énergie, aujourd'hui totalement cloisonnés, voilà le défi que... (n°364, Businesses, page 2)